Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient.
A 9-year-old immunocompetent male patient with primary central nervous system anaplastic large cell lymphoma was treated with 5 cycles of intensive chemotherapy including high-dose Ara-C, high-dose methotrexate, etoposide, and carmustine along with intraventricular chemotherapy followed by high-dose thiotepa and carboplatin with autologous peripheral blood hematopoietic stem cell transplantation. He received radiotherapy as the final therapy and has remained in remission for 26 months off therapy.
Ozkaynak
Mehmet Fevzi
MF
Section of Hematology/Oncology, Department of Pediatrics, New York Medical College, New York, NY 10595, USA. mehmet_ozkaynak@nymc.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000628:therapy*; D002648:Child; D006801:Humans; D007121:Immunocompetence; D017728:Lymphoma, Large-Cell, Anaplastic / Q000628:therapy*; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation; D012074:Remission Induction / Q000379:methods; D014182:Transplantation, Autologous; D016896:Treatment Outcome